Joining from RLDatix & Allocate Software, Martin Dew will lead TMLEP, scaling services globally to drive resilience within healthcare providers.
TMLEP has appointed Martin Dew as chief executive officer to succeed Oliver Maughan, who is stepping down after more than a decade.
Dew’s appointment will reinforce TMLEP’s commitment to building resilience within healthcare providers, proactively driving improvements in patient safety and clinical outcomes, and positioning the company as a global leader in specialist healthcare consultancy and risk management services.
Under Maughan, TMLEP has transformed the investigation of clinical incidents, significantly enhancing how insurers, legal teams, and healthcare providers resolve liabilities with greater speed, accuracy, and efficiency. He has placed TMLEP on the path toward becoming a hyper-specialist healthcare consultancy, extending its expertise beyond clinical liabilities to proactive, reactive, and preventative clinical risk management.
A pivotal time
Dew joins TMLEP from healthcare technology and workforce software system developer RLDatix & Allocate Software. Throughout his career, including his previous role at OneAdvanced, he has championed technology solutions to enhance healthcare delivery and workforce support.
“It’s a privilege to join TMLEP at such a pivotal time,” said Dew. “The company is uniquely positioned to extend its consultancy and real-time response services globally, helping healthcare providers proactively manage clinical risk, adopt cutting-edge technologies, and improve patient outcomes.”
“Together with outstanding colleagues and key partners, we’ve built an exceptional team and fostered a culture of innovation, creating a robust platform that’s now perfectly positioned for rapid global expansion into healthcare consultancy and clinical risk management,” said Maughan. “Martin has exactly the right expertise, ambition, and energy to lead TMLEP successfully through its next phase, scaling services globally to drive resilience within healthcare providers – ensuring clinical risks are managed effectively, and wherever adverse incidents occur, standards of care and patient safety are continuously improved.”
